Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × decitabine and cedazuridine drug combination × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 5 Myeloproliferative Disorders 3 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Chronic 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Hodgkin Disease 1 GATA2 Deficiency 1 Carcinoma, Merkel Cell 1 Anemia, Refractory, with Excess of Blasts 1 Allogeneic Stem Cell Transplantation 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

pembrolizumab 69 Carboplatin 59 Pemetrexed 51 Cisplatin 39 Paclitaxel 33 Specimen Handling 23 durvalumab 22 Nivolumab 18 Magnetic Resonance Spectroscopy 18 Gemcitabine 17 osimertinib 14 Docetaxel 14 Bevacizumab 12 130-nm albumin-bound paclitaxel 12 atezolizumab 11 Cetuximab 10 cemiplimab 9 Taxes 9 Radiotherapy 9 Drug Therapy 9 Immunoglobulin G 8 Biopsy 8 tislelizumab 7 amivantamab 7 Radiosurgery 7 Observation 7 Fluorouracil 7 Disulfides 7 Oxaliplatin 6 Leucovorin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡